Literature DB >> 23659799

Comparative proteome analysis of lung tissue from patients with idiopathic pulmonary fibrosis (IPF), non-specific interstitial pneumonia (NSIP) and organ donors.

Martina Korfei1, Daniel von der Beck, Ingrid Henneke, Philipp Markart, Clemens Ruppert, Poornima Mahavadi, Bahil Ghanim, Walter Klepetko, Ludger Fink, Silke Meiners, Oliver Holger Krämer, Werner Seeger, Carlo Vancheri, Andreas Guenther.   

Abstract

Among the idiopathic interstitial pneumonias (IIP), the two entities IPF and NSIP seem to be clinically related, but NSIP has a better outcome. The proteomic signatures which distinguish NSIP from IPF remain still elusive. We therefore performed comparative proteomic analysis of peripheral lung tissue from patients with sporadic IPF (n=14) and fibrotic NSIP (fNSIP, n=8) and organ donors (Controls, n=10), by using the 2-dimensional DIGE technique and MALDI-TOF-MS. The study revealed that the proteomic profiles of IPF and fNSIP were quite similar. Among the upregulated proteins in IPF and fNSIP were stress-induced genes involved in the ER stress-pathway, whereas downregulated proteins in IPF and fNSIP included antiapoptotic factors and antifibrotic molecules. The comparison fNSIP versus IPF indicated upregulation of subunits of the proteasome activator complex and antioxidant enzymes of the peroxiredoxin family. We conclude, that only few protein expression changes exist between IPF and fNSIP, and that epithelial ER- and oxidative stress play a major role in the pathogenesis of both diseases. In contrast to IPF, intracellular clearance of ROS and misfolded protein carbonyls seem to be enhanced in fNSIP due to enhanced expression of antioxidant acting proteins, and may explain the better outcome and survival in patients with fNSIP. BIOLOGICAL SIGNIFICANCE: IPF and fibrotic NSIP (fNSIP) belong to the idiopathic interstitial pneumonias and are usually fatal, but fNSIP has a better outcome. In order to identify molecular mechanisms and differences between IPF and fNSIP, we herein present results of a comparative proteome analysis of IPF, fNSIP and control lung tissue. Our data including validation experiments suggest that ER stress and a general stress-response as well as the decline of antioxidant capacity in alveolar epithelium is key in the pathogenesis of IPF and fNSIP. In addition, we could observe a signature of an increased alveolar epithelial protection against oxidative and ER-stress in fNSIP as compared to IPF, which could help to explain the better outcome of fNSIP patients.
Copyright © 2013 The Authors. Published by Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23659799     DOI: 10.1016/j.jprot.2013.04.033

Source DB:  PubMed          Journal:  J Proteomics        ISSN: 1874-3919            Impact factor:   4.044


  21 in total

1.  A proteomics approach to identifying key protein targets involved in VEGF inhibitor mediated attenuation of bleomycin-induced pulmonary fibrosis.

Authors:  Yogesh M Kulkarni; Sucharita Dutta; Anand Krishnan V Iyer; Rajkumar Venkatadri; Vivek Kaushik; Vani Ramesh; Clayton A Wright; Oliver John Semmes; Juan S Yakisich; Neelam Azad
Journal:  Proteomics       Date:  2015-11-24       Impact factor: 3.984

Review 2.  Mechanisms of alveolar epithelial injury, repair, and fibrosis.

Authors:  Rachel C Chambers; Paul F Mercer
Journal:  Ann Am Thorac Soc       Date:  2015-03

Review 3.  Idiopathic Pulmonary Fibrosis: A Genetic Disease That Involves Mucociliary Dysfunction of the Peripheral Airways.

Authors:  Christopher M Evans; Tasha E Fingerlin; Marvin I Schwarz; David Lynch; Jonathan Kurche; Laura Warg; Ivana V Yang; David A Schwartz
Journal:  Physiol Rev       Date:  2016-10       Impact factor: 37.312

4.  Registration of the extracellular matrix components constituting the fibroblastic focus in idiopathic pulmonary fibrosis.

Authors:  Jeremy Herrera; Colleen Forster; Thomas Pengo; Angeles Montero; Joe Swift; Martin A Schwartz; Craig A Henke; Peter B Bitterman
Journal:  JCI Insight       Date:  2019-01-10

Review 5.  Endoplasmic reticulum stress in the pathogenesis of fibrotic disease.

Authors:  Jonathan A Kropski; Timothy S Blackwell
Journal:  J Clin Invest       Date:  2018-01-02       Impact factor: 14.808

6.  ATF3 and extracellular matrix-related genes associated with the process of chronic obstructive pulmonary.

Authors:  Jia Ye; Li Wen; De-Ling Liu; Guo-xiang Lai
Journal:  Lung       Date:  2014-08-14       Impact factor: 2.584

7.  MAP1LC3B overexpression protects against Hermansky-Pudlak syndrome type-1-induced defective autophagy in vitro.

Authors:  Saket Ahuja; Lars Knudsen; Shashi Chillappagari; Ingrid Henneke; Clemens Ruppert; Martina Korfei; Bernadette R Gochuico; Saverio Bellusci; Werner Seeger; Matthias Ochs; Andreas Guenther; Poornima Mahavadi
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2015-12-30       Impact factor: 5.464

Review 8.  Peroxiredoxins and Beyond; Redox Systems Regulating Lung Physiology and Disease.

Authors:  Evan A Elko; Brian Cunniff; David J Seward; Shi Biao Chia; Reem Aboushousha; Cheryl van de Wetering; Jos van der Velden; Allison Manuel; Arti Shukla; Nicholas H Heintz; Vikas Anathy; Albert van der Vliet; Yvonne M W Janssen-Heininger
Journal:  Antioxid Redox Signal       Date:  2019-04-05       Impact factor: 8.401

Review 9.  Fibrosis: Lessons from OMICS analyses of the human lung.

Authors:  Guoying Yu; Gabriel H Ibarra; Naftali Kaminski
Journal:  Matrix Biol       Date:  2018-03-19       Impact factor: 11.583

10.  New Strategies and Challenges in Lung Proteomics and Metabolomics. An Official American Thoracic Society Workshop Report.

Authors:  Russell P Bowler; Chris H Wendt; Michael B Fessler; Matthew W Foster; Rachel S Kelly; Jessica Lasky-Su; Angela J Rogers; Kathleen A Stringer; Brent W Winston
Journal:  Ann Am Thorac Soc       Date:  2017-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.